Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-216-5 | CAS number: 21112-37-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral LD50 (Rat) >2000 mg/Kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-05-23 to 2018-06-07
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- Deviations have no presumed impact on the outcome or integrity of the study
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Emerald Kalama Chemical Ltd (UK); Batch no: A180118C
- Expiration date of the lot/batch: 2019-06-06
- Purity test date: 2018-02-07
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (15-25°C, ≤70 RH%), under inert gas, Protected from humidity (tight closed container)
- Stability under test conditions: Not specified
- Solubility and stability of the test substance in the solvent/vehicle: Not specified
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
was freshly formulated at a concentration of 200 mg/mL in the vehicle (PEG 400 (poly ethylene glycol)), in the Pharmacy of Citoxlab Hungary Ltd. on the day of administration. The formulation container was stirred continuously up to finishing the treatment.
FORM AS APPLIED IN THE TEST (if different from that of starting material) : Clear, pale yellow liquid - Species:
- rat
- Strain:
- Wistar
- Remarks:
- CRL:(WI)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: Young healthy adult rats, 11 weeks old
- Weight at study initiation: 220 – 229 g
- Fasting period before study: On the night before treatment, the animals were fasted. The food but not water was withheld during an overnight period.
- Housing: 3 animals / cage (Type II polypropylene/polycarbonate)
- Diet (e.g. ad libitum): ssniff®SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest, Germany (Batch no.: 883 29966, expiry date: 31 October 2018), ad libitum
- Water (e.g. ad libitum): tap water from the municipal supply, as for human consumption from 500 ml bottles, ad libitum.
- Acclimation period: at least 27 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 40 -78%
- Air changes (per hr): 15 – 20 air exchanges/hour
- Photoperiod (hrs dark / hrs light): Lighting 12 hours daily, from 6.00 am to 6.00 pm
IN-LIFE DATES: From: 2018-04-26 To: 2018-06-07 - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/Kg bw
- Justification for choice of vehicle: The selection of the vehicle was made during trial formulations with the test item. In order of preference, recommended vehicles were: distilled water, 0.5 or 1% methyl cellulose, PEG 400, corn oil, sunflower oil or DMSO (Dimethyl sulfoxide). On the basis of the trial formulations with the test item, the vehicle used was PEG 400 (poly ethylene glycol). Although no historical control data is available for the OECD 423 study at the test facility, PEG 400 is used routinely both in acute and repeated dose studies without any complications.
- Lot/batch no. (if required): A0378559
MAXIMUM DOSE VOLUME APPLIED: 10 mL/Kg bw
DOSAGE PREPARATION (if unusual): The test item was freshly formulated at a concentration of 200 mg/mL in the vehicle, in the Pharmacy of Citoxlab Hungary Ltd. on the day of administration. The formulation container was stirred continuously up to finishing the treatment.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: A limit of 2000 mg/kg bw dose was selected as the starting dose level which was most likely to produce mortality in some of the dosed animals. Initially, three females (assigned to Group 1) were treated at a dose level of 2000 mg/kg bw. The test item did not cause mortality in this group and a second group (Group 2) was treated at the same dose level. No mortality was observed in the confirmatory group, therefore no further testing was required according to OECD 423 and Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.tris test guidelines. - Doses:
- Single oral gavage dose of 2000 mg/Kg bw
- No. of animals per sex per dose:
- 6
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Individual observations were performed on the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
The body weight was recorded on the day before treatment (Day -1), on the day of the treatment (Day 0), Day 7 and Day 14.
- Necropsy of survivors performed: yes
All animals were subjected to a necropsy and a macroscopic examination. All animals were exsanguinated after verification of narcosis following an injection of pentobarbital sodium (Euthanimal 40%; Lot No.: 1609291-03, Expiry Date: 31 October 2019, Produced by: Alfasan International B.V.). After examination of the external appearance, the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs were observed. All gross macroscopic changes were recorded for each animal.
- Other examinations performed: clinical signs, body weight - Statistics:
- The method used was not intended to allow the calculation of a precise LD50 value.
The test item was ranked into categories of Globally Harmonized Classification System (GHS (rev. 7) 2017).
Clinical signs, body weight, body weight gain and gross macroscopic data were tabulated. - Preliminary study:
- Initially, three females (assigned to Group 1) were treated at a dose level of 2000 mg/Kg body weight (bw). The test material did not cause mortality in this group therefore
a confirmatory group (Group 2) was treated at the same dose level. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed at a dose level of 2000 mg/Kg bw.
- Clinical signs:
- other: Treatment with the test material at 2000 mg/Kg bw did not cause any clinical signs.
- Gross pathology:
- No macroscopic findings were observed in Crl:WI wistar female rats given a single dose of the test material at 2000 mg/Kg bw by oral gavage.
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study, the acute oral LD50 value of the test material (2-tert-butyl-1,4-dimethoxybenzene) was determined to be above 2000 mg/Kg bw in female CRL:(WI) rats.
According to the GHS criteria, 2-tert-butyl-1,4-dimethoxybenzene can be classified as "Category 5" or “Unclassified” for acute oral exposure. - Executive summary:
In a key study, the single-dose oral toxicity of the test material (2-tert-butyl-1,4-dimethoxybenzene) was evaluated in Crl:WI rats according to the acute toxic class method (OECD Guideline 423).
Initially, three females (assigned to Group 1) were treated at a dose level of 2000 mg/Kg bw. The test material did not cause mortality in this group, therefore a confirmatory group (Group 2) was treated at the same dose level. The test material did not cause mortality in the confirmatory group, so no further testing was required as per Guideline recommendations.
A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test material was administered formulated in formulated in PEG 400 (poly ethylene glycol) at a concentration of 200 mg/mL at a dose volume of 10 mL/kg bw.
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0 and 7 and Day 14. All animals were subjected to a necropsy and a macroscopic examination.
No mortality was observed through the study period and there was no evidence of clinical toxicity subsequent to treatment at 2000 mg/Kg bw. Normal body weight gain was observed in the observation period. However, one animal exhibited slight body weight loss between Day 7 and Day 14. This change was considered incidental and minimal and not treatment-related. No macroscopic findings were observed in Crl: WI wistar female rats.
Under the conditions of this study, the acute oral LD50 value of the test material (2-tert-butyl-1,4-dimethoxybenzene) was determined to be above 2000 mg/Kg bw in female CRL:(WI) rats.
According to the GHS criteria, the test material (2-tert-butyl-1,4-dimethoxybenzene) can be classified as "Category 5" or “Unclassified” for acute oral exposure.
Reference
Table 1. Clinical Observations |
||||||||||||||||
Cage No. |
Animal Number |
Observations |
Observation days |
Frequency |
||||||||||||
0 |
1 |
2 |
3 |
2 |
5 |
6 |
7-14 |
|||||||||
30’ |
1h |
2h |
3h |
4h |
6h |
|||||||||||
1 |
3720 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
3721 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
|
3722 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
|
2 |
3723 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
3724 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
|
3725 |
Symptom Free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
20/20 |
+ = present
' = minute
h = hour (s)
Frequency of observation = number of occurrence of observation / total number of observations
Table 2. Body Weight Data |
|||||||||
Cage No. |
Animal Number |
Body weight (g) Days |
Body Weight Gain (g) |
||||||
-1 |
0 |
7 |
14 |
-1-0 |
0-7 |
7-14 |
-1-14 |
||
1 |
3720 |
246 |
227 |
256 |
272 |
-19 |
29 |
16 |
26 |
3721 |
245 |
229 |
253 |
255 |
-16 |
24 |
2 |
10 |
|
3722 |
237 |
221 |
252 |
257 |
-16 |
31 |
5 |
20 |
|
2 |
3723 |
230 |
221 |
240 |
239 |
-9 |
19 |
-1 |
9 |
3724 |
232 |
220 |
265 |
273 |
-12 |
45 |
8 |
41 |
|
3725 |
230 |
220 |
262 |
262 |
-10 |
42 |
0 |
32 |
|
Mean |
236.7 |
223.0 |
254.7 |
259.7 |
-13.7 |
31.7 |
5.0 |
23.0 |
|
Standard Deviation |
7.3 |
3.9 |
8.8 |
12.6 |
3.9 |
10.1 |
6.3 |
12.6 |
Table 3. Necropsy Findings |
|||||
Cage No. |
Animal Number |
Necropsy Date/ Necropsy Day |
External Observations |
Internal Observations |
Organ/Tissue |
1 |
3720 |
06 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
3721 |
06 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
|
3722 |
06 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
|
2 |
3723 |
07 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
3724 |
07 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
|
3725 |
07 June 2018 Day 14 |
No external observations recorded |
No internal observations recorded |
Not Applicable |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In a key study (Citoxlab, 2019), the single-dose oral toxicity of the test material (2-tert-butyl-1,4-dimethoxybenzene) was evaluated in Crl:WI rats according to the acute toxic class method (OECD Guideline 423).
Initially, three females (assigned to Group 1) were treated at a dose level of 2000 mg/Kg bw. The test material did not cause mortality in this group, therefore a confirmatory group (Group 2) was treated at the same dose level. The test material did not cause mortality in the confirmatory group, so no further testing was required as per Guideline recommendations.
A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment. The test material was administered formulated in formulated in PEG 400 (poly ethylene glycol) at a concentration of 200 mg/mL at a dose volume of 10 mL/kg bw.
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0 and 7 and Day 14. All animals were subjected to a necropsy and a macroscopic examination.
No mortality was observed through the study period and there was no evidence of clinical toxicity subsequent to treatment at 2000 mg/Kg bw. Normal body weight gain was observed in the observation period. However, one animal exhibited slight body weight loss between Day 7 and Day 14. This change was considered incidental and minimal and not treatment-related. No macroscopic findings were observed in Crl: WI wistar female rats.
Under the conditions of this study, the acute oral LD50 value of the test material (2-tert-butyl-1,4-dimethoxybenzene) was determined to be above 2000 mg/Kg bw in female CRL:(WI) rats.
According to the GHS criteria, the test material (2-tert-butyl-1,4-dimethoxybenzene) can be classified as "Category 5" or “Unclassified” for acute oral exposure.
Justification for classification or non-classification
2-tert-butyl-1,4-dimethoxybenzene does not meet the criteria to be classified for acute oral toxicity under EU Regulation (EC) No 1272/2008 (CLP). However, according to the GHS criteria, based on an oral LD50 of >2000 mg/Kg bw, the test material can be classified as "Category 5" or “Unclassified” for acute oral exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.